A Study of Enzalutamide Plus the Glucocorticoid Receptor Antagonist Relacorilant Versus Placebo for Patients With High-risk Localized Prostate Cancer
Abroad (travel likely)RecruitingPHASE2
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Conditions
Prostate Cancer · Prostate Adenocarcinoma
Locations
- University of Chicago Comprehensive Cancer Center, Chicago, Illinois, United States
- University of Texas Southwestern Medical Center, Dallas, Texas, United States